Physician profile
Daniel J Gianoli
NPI 1841430097
$7,660.69
in general payments reported to CMS, 2019-2025
25 companies · $2,035 in 2025
The $2,035 reported for 2025 was more than what 82% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,031 · 2020: $541 · 2021: $740 · 2022: $603 · 2023: $615 · 2024: $1,096 · 2025: $2,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,518 · Travel and Lodging: $1,058 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,517.75 |
| Travel and Lodging | $1,058.12 |
| Education | $169.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,920.26 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Corevalve Evolut R |
| Boston Scientific Corporation | $1,737.08 | 2019-2025 | Intracept |
| Vertiflex, INC. | $1,148.30 | 2019 | |
| Abbott Laboratories | $607.41 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $444.70 | 2022-2023 | Relistor |
| Curonix LLC | $297.38 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $216.15 | 2023-2025 | Belbuca, Xtampza |
| Medtronic USA, INC. | $191.84 | 2019-2020 | |
| Stryker Corporation | $150.00 | 2024 | Mild Device Kit |
| Tersera Therapeutics LLC | $121.00 | 2024-2025 | Prialt |
| Forte Bio-Pharma LLC | $111.37 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Allergan, INC. | $103.01 | 2019-2021 | |
| Nevro Corp. | $101.08 | 2019 | |
| Painteq LLC | $79.30 | 2021 | |
| Si-Bone, INC. | $69.62 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.22 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $59.18 | 2025 | |
| Vertos Medical, INC. | $52.49 | 2021-2024 | Mild Device Kit |
| Spinal Simplicity, LLC | $37.84 | 2025 | Ha Minuteman G3-R |
| Bioventus LLC | $34.17 | 2022 | |
| Foundation Fusion Solutions, LLC | $27.97 | 2023-2024 | |
| Relievant Medsystems, INC. | $26.20 | 2019-2021 | |
| Abbvie INC. | $22.72 | 2023 | |
| Biodelivery Sciences International, INC. | $18.15 | 2020 | |
| Scilex Pharmaceuticals INC. | $17.25 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gianoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.